Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value (euro) 0.01 per share
-
Shares outstanding
-
120,761,877
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
92,278,281
-
Shares change
-
+16,411,275
-
Total reported value, excl. options
-
$656,009,984
-
Value change
-
+$109,309,792
-
Put/Call ratio
-
132%
-
Number of buys
-
48
-
Number of sells
-
-47
-
Price
-
$7.11
Significant Holders of Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share (IMTX) as of Q4 2024
116 filings reported holding IMTX - Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share as of Q4 2024.
Immatics N.V. - Ordinary Shares, nominal value (euro) 0.01 per share (IMTX) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92,278,281 shares
of 120,761,877 outstanding shares and own 76% of the company stock.
Largest 10 shareholders include T. Rowe Price Investment Management, Inc. (10,604,777 shares), WELLINGTON MANAGEMENT GROUP LLP (10,417,892 shares), PERCEPTIVE ADVISORS LLC (9,383,456 shares), BAKER BROS. ADVISORS LP (7,275,830 shares), RTW INVESTMENTS, LP (6,540,540 shares), Vestal Point Capital, LP (6,275,000 shares), Paradigm Biocapital Advisors LP (5,414,409 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5,065,277 shares), BRAIDWELL LP (3,503,965 shares), and ORBIMED ADVISORS LLC (3,087,462 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.